Inogen | INGN - Interest Expense On Debt


Inogen reported 1.03M in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
AngioDynamics USD 100K 134K Feb/2025
AtriCure USD 1.35M 79K Jun/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 153M 2M Dec/2025
Boston Scientific USD 90M 3M Dec/2025
Chart Industries USD 77.1M 1.2M Sep/2025
Cooper Companies USD 24.4M 1000K Sep/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Globus Medical USD 5.1B 5.1B Sep/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 7M 2.5M Sep/2025
Masimo USD 8.8M 600K Sep/2025
Medtronic USD 181M 5M Sep/2025
Orthofix International 5.2M 4.71M Sep/2024
Philips EUR 109M 31M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Steris USD 14.9M 0 Dec/2025
Stryker USD 157M 46.17B Sep/2025
Tandem Diabetes Care USD 874.65M 872.75M Sep/2025
Teleflex USD 31.84M 10.13M Sep/2025
Zimmer Biomet Holdings USD 71.9M 3.5M Dec/2025